This work is licensed under a Creative Commons Attribution 4.0 International License.
SEQ ID NO.1 of Patent CN113912739A
General Information
DRACP ID DRACP06016
Peptide Name SEQ ID NO.1 of Patent CN113912739A
Sequence QRDMHSHRDFQPVLVALNSPLSGGMRDRG
Sequence Length 29
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides α6β1 inhibitor
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target α6β1
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C137H222N48O42S2
Absent amino acids CEIKTWY
Common amino acids R
Mass 377730
Pl 10.25
Basic residues 6
Acidic residues 3
Hydrophobic residues 7
Net charge 3
Boman Index -8793
Hydrophobicity -82.76
Aliphatic Index 63.79
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 7
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN113912739A
Patent Title Endostatin 33 peptide with anti-tumor activity and application thereof
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.